by CRA School | Oct 12, 2013 | Articles
By adding a second drug to the diabetes drug rosiglitazone, adverse events dropped enormously. That suggests that drugs could be repurposed to improve drug safety The research is published online on Oct. 9 in the journal Science Translational Medicine. The approach is...
